Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's EBIT?
- Rigel Pharmaceuticals (RIGL) reported EBIT of $11.89M in Q1 2026.
- How has Rigel Pharmaceuticals's EBIT changed year-over-year?
- Rigel Pharmaceuticals's EBIT decreased by 7.0% year-over-year, from $12.77M to $11.89M.
- What is the long-term trend for Rigel Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's EBIT has grown at a 78.0% compound annual growth rate (CAGR), from -$12.5M to $125.47M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Rigel Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude